Zobrazeno 1 - 4
of 4
pro vyhledávání: '"ehsan yazdandoust"'
Autor:
Seyyede Fatemeh Shams, Hossein Ayatollahi, Mohammad hadi Sadeghian, Monavar Afzal Aghaee, Sepideh Shakeri, Ehsan Yazdandoust, Maryam Sheikhi, Nafiseh Amini, Samane Bakhshi, Afsane Bahrami
Publikováno v:
Iranian Journal of Pathology, Vol 13, Iss 4, Pp 397-402 (2018)
Background and Objective: Janus kinase 2 (JAK2) and Myeloproliferative Leukemia (MPL) mutations are confirmatory indicators for Myeloproliferative Neoplasm (MPN). The current study was performed to determine the frequency of MPL mutation in MPN patie
Externí odkaz:
https://doaj.org/article/1239c9ce19c34d77b0b6d68ad2629fba
Autor:
ehsan yazdandoust, mohammad hadidi sadeghian, seyyede fatemeh shams, Yasaman Saadatpour, payam siyadat, maryam sheikhi, Monavar Afzal Aghaee, Hossein Ayatollahi
Publikováno v:
Iranian Journal of Pathology. 17:419-426
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fe74e6c919c0df65515845a885e2a140
https://doi.org/10.30699/ijp.2022.543485.2776
https://doi.org/10.30699/ijp.2022.543485.2776
Autor:
Ehsan, Yazdandoust, Mohammad Hadi, Sadeghian, Seyyede Fatemeh, Shams, Hossein, Ayatollahi, Yasaman, Saadatpour, Payam, Siyadat, Maryam, Sheikhi, Monavvar, Afzalaghaee
Publikováno v:
Iranian journal of pathology. 17(4)
Acute myeloid leukemia (AML) is a hematopoietic malignancy caused by genetic abnormalities. Currently, molecular and genetic factors are routinely used as diagnostic and prognostic markers. FLT-3 is one of the most known diagnostic factors in AML.For
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2861288f516523fd0372dc3d599017de
https://pubmed.ncbi.nlm.nih.gov/36532642
https://pubmed.ncbi.nlm.nih.gov/36532642
Autor:
Mohammad Hadi Sadeghian, Masumeh Ghazanfarpour, Hossein Ayatollahi, Ehsan Yazdandoust, Maryam Sheikhi, Seyyede Fatemeh Shams, Arezoo Shajiei, Sepideh Shakeri
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 10, Iss 1, Pp 1-7 (2017)
Objective/background: Acute myeloid leukemia (AML) is defined as leukemic blast reproduction in bone marrow. Chromosomal abnormalities form different subgroups with joint clinical specifications and results. t(8;21)(q22;q22) and inv(16)(p13;q22) form
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::327a1b241919e27e204f00f9d91d6b03